Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether alpha-lipoic acid and acetyl-L-carnitine
will lower systemic inflammation in patients with Sickle Cell Disease by reducing oxidative
stress, which will result in a decrease in the frequency of vaso-occlusive pain episodes and
improve their quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital & Research Center Oakland UCSF Benioff Children's Hospital Oakland
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)